0001213900-19-025179 Sample Contracts

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • December 3rd, 2019 • Intec Pharma Ltd. • Pharmaceutical preparations • Illinois

REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of December 2, 2019, by and between INTEC PHARMA LTD., a company organized and existing under the laws of the State of Israel, company number 513022780 (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Ordinary Shares Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

AutoNDA by SimpleDocs
ORDINARY SHARES PURCHASE AGREEMENT
Ordinary Shares Purchase Agreement • December 3rd, 2019 • Intec Pharma Ltd. • Pharmaceutical preparations

ORDINARY SHARES PURCHASE AGREEMENT (the “Agreement”), dated as of December 2, 2019 by and between INTEC PHARMA LTD., a company organized and existing under the laws of the State of Israel, company number 513022780 (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.

Intec Pharma Ltd. Jerusalem 9777512 Israel Ladies and Gentleman:
Ordinary Shares Purchase Agreement • December 3rd, 2019 • Intec Pharma Ltd. • Pharmaceutical preparations

We have acted as counsel for Intec Pharma Ltd., a company limited by shares and organized under the laws of the State of Israel (the “Company”), in connection the Ordinary Shares Purchase Agreement, dated December 2, 2019 (the “Sales Agreement”), by and between the Company and Aspire Capital Fund, LLC (the “Buyer”), pursuant to which the Company may sell and issue, from time to time, up to $10,000,000 of ordinary shares of the Company, no par value (the “Ordinary Shares”) as well as 612,520 ordinary shares of the Company, no par value to the Buyer (the “Commitment Shares”). The Ordinary Shares and the Commitment Shares will be issued under the Company’s registration statement on Form S-3 (File No. 333-230016) (the “Registration Statement”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!